Q4 2020 Holdings
Filed 2021-02-16 | 12 holdings | $29.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc.(CRNX) | Common Stock | 22663K107 | $28.7M | 2,030,616 | 96.8% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $465.5K | 3,040,462 | 1.6% |
| Inari Medical, Inc.(NARIUSD) | Common Stock | 45332Y109 | $200.6K | 2,298,217 | 0.7% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $91.0K | 3,292,339 | 0.3% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $54.2K | 5,003,892 | 0.2% |
| Flexion Therapeutics, Inc. | Common Stock | 33938J106 | $44.3K | 3,842,578 | 0.1% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $30.3K | 1,465,384 | 0.1% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $20.1K | 777,727 | 0.1% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $17.5K | 4,450,638 | 0.1% |
| Aprea Therapeutics, Inc. | Common Stock | 03836J102 | $7.0K | 1,426,328 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $3.1K | 543,753 | 0.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $489 | 101,855 | 0.0% |